Prescription drug · NDA
Sodium Sulfate, Potassium Sulfate And Magnesium Sulfate NDC 52536-177
sodium sulfate, potassium sulfate, magnesium sulfate · Sodium sulfate 13.13 g/133.1mL + 2 more ingredients · Solution, Concentrate · Oral · Wilshire Pharmaceuticals, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 52536-177-01 | 52536017701 | 2 BOTTLE, PLASTIC in 1 CARTON (52536-177-01) / 133.1 mL in 1 BOTTLE, PLASTICMarketed from Apr 15, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Sodium Sulfate, Potassium Sulfate And Magnesium Sulfate
- Generic name (nonproprietary)
- sodium sulfate, potassium sulfate, magnesium sulfate
- Active ingredients
- Sodium sulfate — 13.13 g/133.1mLPotassium sulfate — 2.35 g/133.1mLMagnesium sulfate, Unspecified form — 1.2 g/133.1mL
- Dosage form
- Solution, Concentrate
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 022372
- Marketing start
- Listing expires
- Other FDA classes
- Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Small Intestine Fluid/Electrolyte Absorption (Physiologic effect)Magnesium Ion Exchange Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Potassium Compounds (Chemical structure)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)
- Identifiers
- Product ID 52536-177_f269929e-c2ff-4288-9d3b-7770bcb5a498SPL ID f269929e-c2ff-4288-9d3b-7770bcb5a498SPL set ID f269929e-c2ff-4288-9d3b-7770bcb5a498RxCUI 1001689, 1120068, 2390767UNII 1K573LC5TV, 0YPR65R21J, DE08037SABUPC 0352536174015
- Pharmacologic class
- Calculi Dissolution Agent; Osmotic Laxative; Potassium Salt
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N452536017701followed by a unit qualifier and the quantityPackage 52536-0177-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution is indicated for cleansing of the colon as a preparation for colonoscopy in adult and pediatric patients 12 years of age and older. Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution is an osmotic laxative indicated for cleansing of the colon in preparation for colonoscopy in adult and pediatric patients 12 years of age and older. ( 1 )
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 022372
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| SUPREP Bowel Prepsodium sulfate, potassium sulfate, magnesium sulfate | Sodium sulfate 17.5 g/mL + 2 more ingredients | Solution, ConcentrateOral | Braintree Laboratories, Inc. | 52268-012 |
| SUPREP Bowel Prepsodium sulfate, potassium sulfate, magnesium sulfate | Sodium sulfate 13.13 g/133.1mL + 2 more ingredients | Solution, ConcentrateOral | Braintree Laboratories, Inc. | 52268-112 |
| Sodium Sulfate, Potassium Sulfate And Magnesium Sulfatesodium sulfate, potassium sulfate, magnesium sulfate | Sodium sulfate 17.5 g/mL + 2 more ingredients | Solution, ConcentrateOral | Affordable Pharmaceuticals, LLC | 10572-012 |
| Sodium Sulfate, Potassium Sulfate And Magnesium Sulfatesodium sulfate, potassium sulfate, magnesium sulfate | Sodium sulfate 13.13 g/133.1mL + 2 more ingredients | Solution, ConcentrateOral | Affordable Pharmaceuticals, LLC | 10572-112 |
| SUPREP Bowel Prepsodium sulfate, potassium sulfate, magnesium sulfate | Sodium sulfate 17.5 g/mL + 2 more ingredients | Solution, ConcentrateOral | Azurity Pharmaceuticals, Inc. | 24338-175 |
| SUPREP Bowel Prepsodium sulfate, potassium sulfate, magnesium sulfate | Sodium sulfate 13.13 g/133.1mL + 2 more ingredients | Solution, ConcentrateOral | Azurity Pharmaceuticals, Inc. | 24338-177 |
| Sodium Sulfate, Potassium Sulfate And Magnesium Sulfatesodium sulfate, potassium sulfate, magnesium sulfate | Sodium sulfate 17.5 g/mL + 2 more ingredients | Solution, ConcentrateOral | Wilshire Pharmaceuticals, Inc. | 52536-175 |